Effective maintenance treatment--breaking the cycle of bipolar disorder.
Clinical guidelines for treatment and research of bipolar disorder greatly benefit from the synthesis of data from individual studies. The British Association for Psychopharmacology bases its guidelines on evidence from opinions (level D) to systematic reviews of primary trial data (level A). The report details conclusions of its 1-day consensus meeting to develop guidelines covering diagnosis, clinical management, pharmacotherapy for acute episodes, relapse prevention and treatment discontinuation. Monotherapy for long-term management is preferred, having reduced side-effects and drug interactions and improved compliance. Combination therapy is often preferred for acute episodes, using antipsychotics for mania or antidepressants for depression. Increased efficacy may be attributed to multiple mechanisms of action and potentially lower doses. In clinical practice, maintenance monotherapy has limited success for chronic episodes and polypharmacy is frequently used, though the best combination remains unclear. A new collaborative approach based on simple clinical trials is required to change current medical practice.
Goodwin
Guy
G
Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. guy.goodwin@psych.ox.ac.uk
Vieta
Eduard
E
D018692:Antimanic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D000077152:Olanzapine; D010349:Patient Compliance / Q000523:psychology; D055502:Secondary Prevention; D016896:Treatment Outcome
D018692:Antimanic Agents; D001569:Benzodiazepines; D000077152:Olanzapine